论文信息 - Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4) - 字舞流文

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4)

T. Naito | T. Takahashi | H. Murakami | A. Sarashina | T. Tamura | N. Yamamoto | H. Nokihara | M. Shahidi | Y. Nakamura | K. Nishio | Y. Seki | T. Takahashi